Ondansetron Oral Soluble Pellicles Effectively Reduce the Incidence of Postoperative Nausea and Vomiting Following Primary Total Joint Arthroplasty: A Randomized Controlled Trial. | Synapse
Ondansetron Oral Soluble Pellicles Effectively Reduce the Incidence of Postoperative Nausea and Vomiting Following Primary Total Joint Arthroplasty: A Randomized Controlled Trial.
This research aims to evaluate the effectiveness of ondansetron oral soluble pellicles in reducing postoperative nausea and vomiting after joint surgery.
Conducted a randomized controlled trial
Assessed patients undergoing total joint arthroplasty
Administered ondansetron oral soluble pellicles
Significant reduction in the incidence of postoperative nausea
Notable decrease in vomiting rates post-surgery
Abstract
Chinese Clinical Trial Registry, ChiCTR2500097588. Registered on 21 February 2025.